|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/138 | (2006.01) |
| A61K 31/44 | (2006.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 1212089 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00954625.0 |
| Date of filing the European patent application | 2000-08-11 | |
| (97) | Date of publication of the European application | 2002-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2006-03-22 |
| (46) | Date of publication of the claims translation | 2006-06-26 |
| (86) | Number | PCT/EP2000/007852 |
| Date | 2000-08-11 |
| (87) | Number | WO 2001/013953 |
| Date | 2001-03-01 |
| (30) | Number | Date | Country code |
| 99116447 | 1999-08-21 | EP |
| (72) |
BEUME, Rolf, DE
BUNDSCHUH, Daniela, CH
HATZELMANN, Armin, DE
SCHUDT, Christian, DE
WEIMAR, Christian, DE
KILIAN, Ulrich, DE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Roflumilasto ir salmeterolio sinergistinis derinys |
| SYNERGISTIC COMBINATION OF ROFLUMILAST AND SALMETEROL |
| Payment date | Validity (years) | Amount | |
| 2017-07-19 | 18 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-08-11 |